Surveillance of gynecologic cancers-cervical, ovarian, uterine-is improving through genetic testing, HPV vaccination, and enhanced screening protocols. Minimally invasive surgery, targeted chemotherapy, and immunotherapy are transforming treatment landscapes. Patient awareness and early detection remain key factors in improving outcomes. Research is also uncovering links between hormonal factors and cancer susceptibility.